Instalab

Oxalic Acid Test 24 Hour Urine

Find out whether your body is producing or absorbing too much of the molecule behind most kidney stones, before stones or silent kidney damage appear.

Should you take a Oxalic Acid test?

This test is most useful if any of these apply to you.

Dealing With Kidney Stones
See whether oxalate is driving your stones and track whether dietary or medical changes are actually lowering your risk.
Living With a Gut Condition
Crohn's, celiac, or past bariatric surgery can silently spike oxalate absorption. This test catches it.
Family History of Hyperoxaluria
Primary hyperoxaluria is inherited, and family screening catches disease even before symptoms appear.
Taking High-Dose Vitamin C
Doses above 1,000 mg/day can increase your oxalate output by 20-39%. This test shows your actual exposure.

About Oxalic Acid

About 80% of kidney stones are made of calcium oxalate. But most people who form these stones never learn how much oxalate their body is actually excreting, because standard blood work and routine urinalysis do not measure it. A 24-hour urine oxalate test fills that gap. It tells you exactly how much oxalate your kidneys are clearing over a full day, and whether that amount is high enough to put you at risk for stones, kidney damage, or both.

What makes this test especially useful is that elevated oxalate can silently damage kidneys even without forming a single stone. Oxalate crystals irritate and inflame the tiny tubes inside your kidneys, triggering scarring that gradually erodes kidney function. Catching high excretion early, and tracking it over time, gives you something actionable before the damage becomes irreversible.

What Oxalate Is and Where It Comes From

Oxalate (also called oxalic acid) is a small organic molecule with two acid groups. Your body cannot break it down or use it for energy. It is a dead-end waste product, and the only significant way to get rid of it is through the kidneys. Once filtered into urine, oxalate binds tightly to calcium, forming calcium oxalate, one of the least soluble salts in the body. When there is too much of it, crystals form.

Your liver manufactures the majority of urinary oxalate, roughly 50-80% under normal conditions, as a byproduct of amino acid metabolism (particularly from glycine, serine, and alanine). The rest comes from dietary absorption. Foods like spinach, rhubarb, nuts, and chocolate are especially rich in oxalate. How much dietary oxalate you absorb depends heavily on how much calcium you eat at the same time, because calcium binds oxalate in the gut and prevents it from reaching the bloodstream.

A third, often overlooked contributor is your gut bacteria. Certain species, especially Oxalobacter formigenes, break down oxalate in the colon before it can be absorbed. People who carry these bacteria tend to have lower urinary oxalate and fewer kidney stones.

Kidney Stone Risk

The relationship between urinary oxalate and kidney stones is not a simple threshold. A large study analyzing over 9,000 urine collections found that stone risk rises in a substantially linear fashion as urinary oxalate increases, with no safe floor below which risk disappears. Among the major urinary risk factors for stones (calcium, volume, citrate, oxalate, uric acid, and pH), oxalate ranked as an intermediate contributor. Calcium, urine volume, and citrate had greater relative importance, but oxalate remained independently predictive.

In people with enteric hyperoxaluria (high oxalate absorption caused by gut malabsorption conditions), the connection between oxalate levels and future stones is direct and dose-dependent. Every 20% reduction in urinary oxalate is associated with roughly a 25% reduction in the annual odds of a new stone event. That means even modest improvement matters.

Kidney Disease Progression

Oxalate does not just cause stones. It can damage kidneys independently. In the largest prospective study linking urinary oxalate to kidney outcomes (the CRIC study, which followed 3,123 adults with existing chronic kidney disease for a median of 7.1 years), people in the highest fifth of urinary oxalate excretion had significantly worse outcomes than those in the lowest fifth.

Who Was StudiedWhat Was ComparedWhat They Found
3,123 adults with CKD stages 2-4, followed 7.1 yearsHighest vs. lowest fifth of urinary oxalate (above vs. below about 25 mg/day)33% higher risk of CKD progression, 45% higher risk of reaching end-stage kidney disease
426,896 adults without CKD, followed about 3 yearsAbove vs. below 25 mg/day urinary oxalatePeople above 25 mg/day had higher rates of developing new CKD, especially those with gut malabsorption conditions
2,966 adults without heart disease, followed 10.6 yearsHighest vs. lowest third of dietary oxalate intake (above vs. below 220 mg/day)About 47% higher risk of cardiovascular events; risk increased further when calcium intake was low

Sources: CRIC Study (Waikar et al., 2019); Puurunen et al., 2024; Bahadoran et al., 2022. Note: The cardiovascular finding is based on dietary oxalate intake, not urinary oxalate, so it reflects a related but different measurement.

What this means for you: if your urinary oxalate is above roughly 25 mg per day, you are in the range where kidney risk begins to climb, even if you have never had a stone. The crystals themselves are directly toxic to kidney tissue. They obstruct tiny tubules, damage the lining cells, and activate inflammatory pathways that lead to scarring. Over time, this can erode kidney function quietly.

When Oxalate Becomes Systemic

When kidney function drops below about 30-40 mL/min (roughly stage 3b-4 CKD), the kidneys can no longer keep up with oxalate excretion. Oxalate begins to accumulate in the blood, and calcium oxalate crystals start depositing in organs beyond the kidneys: bones, heart, blood vessels, eyes, and skin. This condition, called systemic oxalosis, is most common in primary hyperoxaluria but can occur in anyone whose kidneys fail while oxalate production or absorption remains high.

In dialysis patients, serum oxalate levels are associated with cardiovascular events. A study of 1,108 European hemodialysis patients found that those in the highest quarter of serum oxalate (a related but different measurement than urinary oxalate) had about 40% higher risk of cardiovascular events and 62% higher risk of sudden cardiac death over four years compared to those in the lowest quarter.

Types of Hyperoxaluria

Elevated urinary oxalate has three main causes, and knowing which one is driving your number determines what you can do about it.

  • Primary hyperoxaluria: A group of rare inherited disorders (types 1, 2, and 3) where the liver overproduces oxalate due to enzyme defects. Type 1 is the most severe, often producing urinary oxalate above 80-100 mg per day. These conditions are present from birth and can lead to kidney failure in childhood or early adulthood if untreated.
  • Enteric (secondary) hyperoxaluria: Caused by increased oxalate absorption from the gut, usually due to fat malabsorption. Common triggers include Crohn's disease, gastric bypass surgery, short bowel syndrome, cystic fibrosis, and chronic pancreatic insufficiency. When fat is not properly absorbed, it binds the calcium in your gut that would normally trap oxalate, leaving more free oxalate available for absorption.
  • Dietary hyperoxaluria: Excessive intake of high-oxalate foods (spinach, rhubarb, beets, nuts, chocolate) or oxalate precursors, particularly combined with low calcium intake. This is the most modifiable cause and often the first thing to address.

One practical way to distinguish primary from secondary hyperoxaluria is to repeat the 24-hour urine collection on different diets. Secondary hyperoxaluria will respond to a low-oxalate diet; primary hyperoxaluria will not, because the excess comes from the liver regardless of what you eat.

Reference Ranges

Men typically excrete more urinary oxalate than women (median roughly 39 mg/day vs. 26-27 mg/day), and excretion tends to increase with age and BMI. Because different labs use different assay methods, and interlaboratory variability can be significant, always compare your results within the same lab over time.

TierRange (mg/24 hours)What It Suggests
NormalLess than 40-45Typical excretion for healthy adults. Stone risk still exists but is not driven primarily by oxalate.
Mild hyperoxaluria40-75Elevated range often seen with dietary excess, mild fat malabsorption, or high vitamin C intake. Stone risk and kidney damage risk are increasing.
Severe hyperoxaluriaAbove 75Raises suspicion for primary hyperoxaluria in adults without bowel dysfunction. Warrants genetic evaluation and specialist referral.

These tiers are drawn from published research and AUA guidelines. Your lab may use different assays and cutpoints. Compare your results within the same lab over time for the most meaningful trend. For children, results must be corrected for body surface area, and age-specific reference ranges apply.

An emerging perspective from kidney disease research suggests that even values above roughly 25 mg/day may carry increased risk for CKD progression. This does not mean everyone above 25 needs treatment, but it does mean that tracking your trend matters even if your result falls within the traditional normal range.

Tracking Your Trend

A single 24-hour oxalate reading is a starting point, not a verdict. Urinary oxalate has substantial natural variation from day to day. In people with primary hyperoxaluria, the average coefficient of variation (a measure of how much the number bounces around between collections) is about 14%, and in some individuals it can be as high as 36%. For people with enteric hyperoxaluria, the variation is even wider: around 27% for idiopathic cases and 41% for those with gut malabsorption.

This means a single collection can easily be 30% higher or lower than your true average. To confirm whether your oxalate is genuinely elevated, at least two separate 24-hour collections are needed. If you are making dietary or supplement changes to lower oxalate, you need your own baseline established before treatment so you can tell whether a later reading represents a real biological change or just normal fluctuation. On average, a reduction of about one-third is needed to confidently say a treatment is working.

Get a baseline with two collections spaced a few weeks apart. If you are making changes (diet, supplements, or medication), retest in 3 to 6 months. After that, annual monitoring is reasonable for most people, with more frequent testing if you have an active stone history or a malabsorption condition.

When Results Can Be Misleading

The 24-hour urine collection is only as good as the collection itself. Several factors can distort your reading and lead to the wrong conclusion.

  • Incomplete or over-collected samples: If you miss urine during the 24-hour window or collect for longer than 24 hours, the result will be falsely low or high. Total volume should be above 500 mL and the collection period should fall between 22 and 26 hours. Creatinine is measured alongside oxalate to check collection adequacy.
  • Vitamin C supplements: Doses of 1,000 mg or more per day increase urinary oxalate by 20-39%, because your body converts some ascorbic acid directly into oxalate. About 40% of people are especially sensitive to this effect. Stop vitamin C supplements at least 48 hours before collecting.
  • Recent high-oxalate meals: Dietary oxalate contributes 24-53% of urinary oxalate. A day of unusually high spinach, rhubarb, or nut intake can spike your collection result above your true baseline.
  • Low calcium intake: Eating very little calcium on the day of collection leaves more free oxalate in your gut to be absorbed, inflating the result. Maintain your normal diet during collection.

Improper sample handling is another common pitfall. Urine must be acidified to pH 2 or below (either during collection or by the lab) to dissolve calcium oxalate crystals that form naturally. Without this step, oxalate binds to calcium in the collection jug and precipitates out, causing the lab to report a falsely low number. Samples with pH above 8 should be rejected due to bacterial contamination risk.

Kidney function itself affects interpretation. When the kidneys' filtration rate drops below about 30-40 mL/min, they can no longer excrete oxalate efficiently. At that point, a normal or even low urinary oxalate does not mean your body is producing normal amounts; it means your kidneys have lost the capacity to clear it. Plasma oxalate becomes the more informative test in advanced kidney disease.

Antibiotics deserve attention too. They can eliminate oxalate-degrading bacteria in the gut, particularly Oxalobacter formigenes, leading to increased oxalate absorption for weeks to months after a course. If you recently completed antibiotics, your reading may be transiently higher than your true baseline. The greatest effect appears 3 to 6 months after antibiotic exposure.

What Moves This Biomarker

Evidence-backed interventions that affect your Oxalic Acid level

Decrease
Take lumasiran (an RNA interference drug targeting glycolate oxidase in the liver)
In patients with primary hyperoxaluria type 1, lumasiran reduced 24-hour urinary oxalate by an average of 65.4% from baseline. At 6 months, 84% of patients reached levels at or below 1.5 times the upper limit of normal, and 52% achieved completely normal oxalate excretion. Reductions began within one month and have been sustained through 60 months of follow-up. This drug works by shutting down an upstream enzyme in the liver that produces the precursor to oxalate.
MedicationStrong Evidence
Decrease
Take nedosiran (an RNA interference drug targeting lactate dehydrogenase A in the liver)
In patients with primary hyperoxaluria types 1 and 2, nedosiran reduced 24-hour urinary oxalate by more than 60% from baseline, sustained through 42 months. About 50% of all patients (65% of those with type 1) reached normal or near-normal oxalate levels. This drug blocks a different step in the liver's oxalate production pathway than lumasiran.
MedicationStrong Evidence
Decrease
Take pyridoxine (vitamin B6) if you have a responsive genetic variant of primary hyperoxaluria type 1
In patients with specific genetic variants of primary hyperoxaluria type 1 (particularly the G170R mutation), pyridoxine at 5-20 mg/kg/day reduced urinary oxalate by 73% in those with two copies of the mutation and 45% in those with one copy. Four of six patients with two copies reached completely normal urinary oxalate. About 30-50% of all primary hyperoxaluria type 1 patients carry a pyridoxine-responsive genotype. Response is typically assessed after 3 months, and benefits have been sustained through 6-8 years of follow-up.
SupplementStrong Evidence
Increase
Take orlistat (a fat-blocking weight loss medication)
Orlistat causes fat malabsorption by design, and the unabsorbed fat binds calcium in the gut, leaving more free oxalate to be absorbed. In a study of patients taking orlistat, 61.8% developed significantly elevated urinary oxalate at 3 months, rising to 88.2% by 6 months. The FDA label includes warnings about both kidney stones and kidney damage from oxalate. If you are taking orlistat, monitoring urinary oxalate is especially warranted.
MedicationStrong Evidence
Decrease
Follow a low-oxalate diet (less than 40-50 mg of dietary oxalate per day)
In a randomized trial of idiopathic hyperoxaluric stone formers, a low-oxalate diet (under 40-50 mg/day) reduced urinary oxalate by a median of 24.3% over 12 weeks. Over 91% of patients saw some decrease. This approach works for dietary and enteric hyperoxaluria but will not meaningfully reduce oxalate in primary hyperoxaluria, where the excess comes from the liver.
DietModerate Evidence
Decrease
Take calcium supplements with meals
Taking 200-300 mg of calcium with meals cuts oxalate absorption roughly in half. In a controlled study, the percentage of a dietary oxalate load absorbed dropped from 18.3% at baseline to 8.1% with calcium carbonate and 7.2% with calcium citrate malate. This works because calcium binds oxalate in the gut, forming insoluble crystals that pass through without being absorbed. Both calcium carbonate and calcium citrate are equally effective.
SupplementModerate Evidence
Decrease
Increase dietary calcium intake to at least 600-800 mg per day
In a study of 94 healthy adults, urinary oxalate excretion decreased progressively as calcium intake increased, with the strongest effect seen up to about 600-800 mg per day. The relationship is curvilinear, meaning the first increases in calcium have the biggest impact on reducing oxalate. Paradoxically, restricting dietary calcium (as was once recommended for stone formers) actually increases urinary oxalate by leaving more free oxalate in the gut for absorption.
DietModerate Evidence
Increase
Take high-dose vitamin C (1,000 mg or more per day)
Vitamin C doses of 1,000 mg or more per day increase urinary oxalate by 20-39% because the body converts some ascorbic acid directly into oxalate. At very high doses (10 g/day), urinary oxalate nearly doubles, rising from about 50 mg to 87 mg per day. About 40% of people are especially sensitive, showing a 31% increase in oxalate absorption and 39% increase in endogenous oxalate production. For anyone at risk of kidney stones, high-dose vitamin C supplementation meaningfully increases stone risk.
SupplementModerate Evidence
Decrease
Take magnesium supplements with meals
In a randomized trial, magnesium supplementation taken with meals reduced 24-hour urinary oxalate by a median of 17.8 mg/day (compared to 8.5 mg/day when taken while fasting). A separate study showed magnesium oxide reduced the percentage of dietary oxalate absorbed from 13.5% to 7.6%. Like calcium, magnesium binds oxalate in the gut, but the benefit depends on taking it with food.
SupplementModest Evidence
Decrease
Take vitamin B6 (25 mg) plus magnesium oxide (400 mg) daily
In a randomized trial of idiopathic hyperoxaluric stone formers, 12 weeks of vitamin B6 (25 mg) and magnesium oxide (400 mg) daily reduced urinary oxalate by a median of 16%. About 68% of patients achieved some decrease. This combination was significantly less effective than a low-oxalate diet in the same trial.
SupplementModest Evidence

Frequently Asked Questions

References

58 studies
  1. Witting C, Langman CB, Assimos DClinical Journal of the American Society of Nephrology2021
  2. Cochat P, Rumsby GThe New England Journal of Medicine2013
  3. Fargue S, Milliner DS, Knight JJournal of the American Society of Nephrology2018